Sensors, artificial intelligence, and virtual reality are some of the advanced technologies that have changed the pharmaceutical sector, and many of these technologies will allow physicians to focus on what makes them good at treating patients. Digital health will also help doctors in performing some of the repetitive tasks that are always monotonous. However, with these six medical specialties, healthcare is poised to benefit greatly.
Several doctors are choosing this specialty to make long term impacts on patients’ lives. Furthermore, general practice specialists boast a lot of trust from their patients. The GPs have also reduced the patient’s time moving from one doctor to the other. They can diagnose an illness, give therapy, and offer health advice. With the wearables that relay a patient’s information to doctors notifying them of vital signs, GPs will be able to provide treatment advice remotely. With smart algorithms in place, the GPs will act as gatekeepers to other specialists and advise on rare diseases.
There is always limited time while examining the health status of a pregnant mother and a baby. Sensors that monitor a mother’s and a child’s crucial signs mean that in emergencies, giving care will not depend on the mother’s luck. For instance, other technologies such as CRISPR are also coming in to treat genetic conditions in kids. The cheap whole-genome sequencing could also help pediatricians to access more information to diagnose and treat children.
The specialty is about to bring tremendous benefits to patients. For example, bionic eyes and renal implants are there to reinstate sight for those who have lost it. Besides, CRISPR has also been used to successfully restore vision from an inherited form of blindness. Smartphones with connected sensors and apps that use the phone’s camera have also been used to diagnose eye conditions of recent.
The specialty is paving the way for precision medicine and targeted treatment. Oncologists are even customizing therapies based on the patient’s tumor molecular makeup and genetic background. The process is even made faster by measuring blood biomarkers and cheap genome sequencing. Furthermore, some companies are also developing fluid biopsies capable of detecting all types of cancer from the early stages. These biopsies are capable of filtering tumor cells from blood samples, enabling doctors to analyze tumors earlier without performing expensive surgeries. This is the sector where companies like Predictive Oncology (NASDAQ: POAI) feature prominently.
Its focus is on the digestive system and its disorders. Focus is to see what is happening in your stomach and how you can be helped. This is now easier; courtesy of a pill cam and millions of people have benefited from this capsule endoscopy. Doctors can now see your esophagus, small bowel, and colon using the capsule to monitor and diagnose the gastrointestinal tract. It can be done without sedating the patient unlike what happens during invasive endoscopic processes. Furthermore, food scanners are also emerging, and they will be beneficial to those with dietary restrictions and food allergies.
Surgery is going to be more informational, driven by artificial intelligence and robotics in the coming years. Digital health is offering an amazing collaboration between humans and technology. The cooperation will raise the level of precision and efficiency of surgeries higher, which you have never experienced before. With all these improvements, digital health is going to be great in the future.
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.